LYME DISEASE DIAGNOSTICS MARKET ANALYSIS

Regional Analysis

Lyme Disease Diagnostics Market Regional Insights

Regional segmentation of lyme disease diagnostics market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America Lyme disease diagnostics market is expected to hold a dominant position over the forecast period. This is due to increasing government initiatives for diagnosing and treatment of various diseases. The Centers for Disease Control and Prevention (CDC) has increased their focus to develop novel strategies for the prevention of Lyme disease, in order to reduce the occurrence of disease in the target populations. Another factor aiding in growth of the market in the region is increasing pervasiveness of common tick disease, which has led to high demand for effective disease treatment. According to a research paper, Lyme disease is the most prevalent tick-borne infection in North America and Europe. It is the most commonly listed vector borne disease in the U.S. so far. According to CDC, in 2015, it was regarded as the sixth most common Nationally Notifiable disease in the country. Europe Lyme disease diagnostics market is expected to exhibit high growth, due to increasing number of infected patients. The incidence of Lyme disease has been increasing significantly in some European countries. According to Center for Health Protection, Lyme disease cases  in Europe are expanding with about 100 cases per 100,000 population every year.